Alzheimer’s disease (AD) is a growing public health concern affecting millions of patients worldwide and costing billions of dollars annually. With regards to the pathophysiology of AD and associated memory loss in AD patients, one of the most relevant defects is the degeneration of cholinergic neurons in the nucleus basalis of Meynert, a group of neurons located in the basal forebrain. Well-known conventional and complementary drugs and treatments are involved in reducing the symptoms of the disease and delaying its progression. Achieving the most optimum treatment strategy for AD, with its growing numbers annually, is a concern of clinical researchers. The use of the Faradarmani Consciousness Fields introduced by Taheri treat biological cells, modifying and optimizing their structures and functions has been reported in recent studies. In our study, we study the influence of Faradarmani Consciousness Field on the spatial memory and avoidance behavior of a rat model of AD. The rats in our study have an inhibited acetylcholine response due to use of the scopolamine, a medication used to treat motion sickness and postoperative nausea and vomiting. According to the results of this study, the Faradarmani Consciousness Field shows a remarkable restorative and restorative-enhancing effect on distorted spatial memory and passive avoidance behavior of AD rat models, respectively.
Keywords: Alzheimer’s disease; Faradarmani Consciousness Field (FCF); memory; scopolamine